Cargando…
CRP was found to be an independent discriminator in COVID19 patients
Autores principales: | Bhagya, K., Subbalakshmi, E., Kalpana Devi, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594365/ http://dx.doi.org/10.1016/j.ijmmb.2021.08.221 |
Ejemplares similares
-
Correlation of CRP levels with severity of COVID-19 patients
por: Shilpa, H.S., et al.
Publicado: (2021) -
Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD
por: Çolak, Ayfer, et al.
Publicado: (2017) -
Seven COVID-19 Patients Treated with C-Reactive Protein (CRP) Apheresis
por: Esposito, Fabrizio, et al.
Publicado: (2022) -
The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022) -
CRP Monitoring in Early Hospitalization: Implications for Predicting Outcomes in Patients with COVID-19
por: Avihai, Byron, et al.
Publicado: (2023)